Skip to main content
Caplight Logo









Rheaplant

Rheaplant

Private
Oakland, CaliforniaHealthcare & Life Scienceshttps://www.rheaplant.com/

Last Round

Accelerator

May 18, 2026

Total Funding Raised

$200,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Rheaplant is a biotechnology company that develops modular, purpose-built plant cell bioprocessing platforms to enable the cost-effective production of botanical ingredients.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clean Manufacturing, Sustainable Materials

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS, Data as a Service

AI Layer

Non-AI

Keywords

plant cell culturebiomanufacturingbotanical ingredientscellular agriculturebioprocessingbioreactornutraceuticalsplatform-as-a-servicePaaSsustainable ingredientscell-line developmentfood techclimate techdecentralized manufacturingbioactive compounds

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Rheaplant Comparables

Compare Rheaplant with similar companies based on industry and business-model similarity.

Rheaplant comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ayana Bio
85%
Chi Botanic
84%
California Cultured
83%

Rheaplant Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorMay 18, 2026
Pre SeedAug 1, 2025

Rheaplant Investors

Notable investors and investment history

Rheaplant investors
InvestorRounds
Big Idea VenturesAccelerator
2045 VenturesPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 18, 2026

    $200K round led by Big Idea Ventures.

Rheaplant Filings

Explore SEC and related filing metadata, where available.

Rheaplant filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Rheaplant's valuation, stock price, and market status.

Is Rheaplant a public or private company?

Rheaplant is a private company.

What is the current stock price of Rheaplant?

Rheaplant is a private company with no public stock price. No recent secondary market data is available.

How much is Rheaplant worth (valuation)?

Valuation information for Rheaplant is not publicly available.

Can I buy Rheaplant stock?

Rheaplant shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Rheaplant's last funding round?

Rheaplant's most recent funding round was Accelerator on May 18, 2026.

Who are the main investors in Rheaplant?

Key investors in Rheaplant include Big Idea Ventures.

Will Rheaplant IPO soon?

No public IPO plans have been announced for Rheaplant.

How can I track Rheaplant secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Rheaplant's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersOakland, California
Year Founded2025
Last FundingMay 18, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?